Compare
Alphatec Holdings, Inc. vs Orthofix Medical Inc. vs UFP Technologies Inc vs Embecta Corp.
| Latest fiscal year | Alphatec Holdings, Inc. ATEC | Orthofix Medical Inc. OFIX | UFP Technologies Inc UFPT | Embecta Corp. EMBC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $764.15M | $822.31M | $602.80M | $1.08B |
| Revenue growth (YoY) | +25.0% | +2.9% | +19.5% | -3.8% |
| Gross margin | 69.6% | 68.8% | 28.3% | 62.6% |
| Operating margin | -10.7% | -9.9% | 15.3% | 22.4% |
| Net margin | -18.8% | -11.2% | 11.3% | 8.8% |
| Net income | -$143.36M | -$92.19M | $68.31M | $95.40M |
| EPS (Diluted) | -$0.96 | -$2.33 | $8.75 | $1.62 |
| Operating cash flow | $45.23M | $33.35M | $91.91M | $191.70M |
| Free cash flow | $2.78M | -$1.28M | n/a | $182.40M |
| Cash & equivalents | $160.81M | $82.03M | $20.30M | $225.50M |
| Total assets | $791.21M | $850.65M | $655.08M | $1.09B |
| Total liabilities | n/a | $400.61M | $231.20M | n/a |
| Shareholders' equity | $12.43M | $450.04M | $423.88M | -$650.60M |
| Return on year-end equity | n/m | -20.5% | 16.1% | n/a |
| Shares outstanding | 150.26M | 39.83M | 7.71M | 58.50M |
Revenue, most recent five fiscal years
| Fiscal year | Alphatec Holdings, Inc. | Orthofix Medical Inc. | UFP Technologies Inc | Embecta Corp. |
|---|---|---|---|---|
| Latest | $764.15M Ended 2025-12-31 | $822.31M Ended 2025-12-31 | $602.80M Ended 2025-12-31 | $1.08B Ended 2025-09-30 |
| 1 year earlier | $611.56M Ended 2024-12-31 | $799.49M Ended 2024-12-31 | $504.42M Ended 2024-12-31 | $1.12B Ended 2024-09-30 |
| 2 years earlier | $482.26M Ended 2023-12-31 | $746.64M Ended 2023-12-31 | $400.07M Ended 2023-12-31 | $1.12B Ended 2023-09-30 |
| 3 years earlier | $350.87M Ended 2022-12-31 | $460.71M Ended 2022-12-31 | $353.79M Ended 2022-12-31 | $1.13B Ended 2022-09-30 |
| 4 years earlier | $243.21M Ended 2021-12-31 | $464.48M Ended 2021-12-31 | $206.32M Ended 2021-12-31 | $1.17B Ended 2021-09-30 |